Knowledge Distillery

Impact of the COVID‐19 pandemic on stroke teleconsultations in Germany in the first half of 2020

Impact of the COVID‐19 pandemic and a national lockdown on hospitalisation for stroke and related 30‐day mortality in France: a nationwide…

Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis

Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network

In this study, recently published in Neurology Neuroimmunology & Neuroinflammation, the authors conducted a survey on the risk of COVID-19 in patients…

Whether and how SARS-CoV-2 outbreak affected in-hospital acute stroke care system is still matter of debate.

Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and…

This nationwide study assessed the impact of the pandemic on stroke hospitalisation rates, patient characteristics, and 30‐day case fatality rates.

The effects of the COVID‐19 pandemic on telemedical care have not been described on a national level.

The objective of this study was to assess patients Quality of life (QoL) and the burden of their caregivers during COVID-19 pandemic and specifically…

Disease-modifying therapies (DMT) for relapsing-remitting MS (RRMS) act on the immune system, suggesting a need for caution during the…

Coronavirus disease (COVID-19) appeared in December 2019 in the Chinese city of Wuhan and has quickly become a global pandemic.